Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation

被引:32
作者
Broglie, Martina A. [1 ]
Soltermann, Alex [2 ]
Rohrbach, David [2 ]
Haile, Sarah R. [3 ]
Pawlita, Michael [4 ]
Studer, Gabriela [5 ]
Huber, Gerard F. [6 ]
Moch, Holger [2 ]
Stoeckli, Sandro J. [1 ]
机构
[1] Kantonsspital St Gallen, Dept Otorhinolaryngol Head & Neck Surg, CH-9007 St Gallen, Switzerland
[2] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland
[3] Kantonsspital St Gallen, Clin Trials Unit, CH-9007 St Gallen, Switzerland
[4] German Canc Res Ctr, Res Program Infect & Canc, Dept Genome Modificat & Carcinogenesis, Heidelberg, Germany
[5] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[6] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, Zurich, Switzerland
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2013年 / 35卷 / 12期
关键词
oropharyngeal squamous cell carcinoma; outcome; survival; HPV; p16; smoking; alcohol; p53; intensity modulated radiotherapy; risk stratification; GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; TONSILLAR CARCINOMAS; HEAD; RADIOTHERAPY; EXPRESSION; PROGNOSIS; RISK;
D O I
10.1002/hed.23231
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundAnalysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity-modulated radiotherapy (IMRT). MethodsOne hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%). ResultsSurvival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high-risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16-positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups. ConclusionsA risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. (c) 2013 Wiley Periodicals, Inc. Head Neck 35: 1698-1706, 2013
引用
收藏
页码:1698 / 1706
页数:9
相关论文
共 50 条
  • [31] Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status
    Molony, Peter
    Kharytaniuk, Natallia
    Boyle, Seamus
    Woods, Robbie S. R.
    O'Leary, Gerard
    Werner, Reiltin
    Heffron, Cynthia
    Feeley, Linda
    Sheahan, Patrick
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (08): : 1680 - 1688
  • [32] The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma
    Aguiar Pastrez, Paula Roberta
    Mariano, Vania Sammartino
    da Costa, Allini Mafra
    Silva, Estela Maria
    Scapulatempo-Neto, Cristovam
    Guimaraes, Denise Peixoto
    Fava, Gilberto
    Zemi Neto, Said Abdala
    Nunes, Emily Montosa
    Sichero, Laura
    Villa, Luisa Lina
    Syrjanen, Kari Juhani
    Longatto-Filho, Adhemar
    JOURNAL OF CANCER, 2017, 8 (06): : 1062 - 1070
  • [33] Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma
    Plath, Michaela
    Broglie, Martina A.
    Forbs, Diana
    Stoeckli, Sandro J.
    Jochum, Wolfram
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 47
  • [34] Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European single-institution analysis
    Bird, T.
    De Felice, F.
    Michaelidou, A.
    Thavaraj, S.
    Jeannon, J. -P.
    Lyons, A.
    Oakley, R.
    Simo, R.
    Lei, M.
    Urbano, Guerrero T.
    CLINICAL OTOLARYNGOLOGY, 2017, 42 (01) : 115 - 122
  • [35] p53 and p16ink4a As Predictive and Prognostic Biomarkers for Nodal metastasis and Survival in A Contemporary Cohort of Penile Squamous Cell Carcinoma
    Mohanty, Sambit K.
    Mishra, Sourav K.
    Bhardwaj, Nitin
    Sardana, Ruhani
    Jaiswal, Sunil
    Pattnaik, Niharika
    Pradhan, Dinesh
    Sharma, Shivani
    Kaushal, Seema
    Baisakh, Manas R.
    Das, Suren
    Pradhan, Manas R.
    Satapathy, Kaliprasad
    Pattnaik, Ashis
    Sharma, Shailendra K.
    Khadenga, Chira R.
    Das, Subodh
    Rath, Debadarshi
    Nanda, Biswajit
    V. Parwani, Anil
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : 510 - 520
  • [36] Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma
    Gorphe, Philippe
    Chekkoury Idrissi, Younes
    Tao, Yungan
    Moya-Plana, Antoine
    Casiraghi, Odile
    Janot, Francois
    Blanchard, Pierre
    Mirghani, Haitham
    Temam, Stephane
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (04): : 1039 - 1045
  • [37] HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study
    Lilja-Fischer, Jacob Kinggaard
    Kristensen, Morten Horsholt
    Lassen, Pernille
    Steiniche, Torben
    Tramm, Trine
    Stougaard, Magnus
    Maare, Christian
    Johansen, Jorgen
    Primdahl, Hanne
    Kristensen, Claus Andrup
    Andersen, Maria
    Eriksen, Jesper Grau
    Overgaard, Jens
    ACTA ONCOLOGICA, 2023, 62 (11) : 1384 - 1388
  • [38] The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies
    Langendijk, J. A.
    Psyrri, A.
    ANNALS OF ONCOLOGY, 2010, 21 (10) : 1931 - 1934
  • [39] Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy
    Carpen, Timo
    Saarilahti, Kauko
    Haglund, Caj
    Markkola, Antti
    Tarkkanen, Jussi
    Hagstrom, Jaana
    Mattila, Petri
    Makitie, Antti
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (08) : 759 - 770
  • [40] p16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters
    Gupta, Shalini
    Pandey, Pinki
    Verma, Sakshi
    Verma, Abhishek
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (03) : 881 - 887